Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 43 clinical trials
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma

camrelizumab in combination with adriamycin, cisplatin, ifosfamide and methotrexate in study population in China. Camrelizumab is a humanized anti-PD1 IgG4 monoclonal antibody.

monoclonal antibodies
methotrexate
measurable disease
cancer chemotherapy
resectable osteosarcoma
  • 0 views
  • 28 Feb, 2022
  • 1 location
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma

safety of camrelizumab in combination with Liposome doxorubicin and Ifosfamide in study population in China. Camrelizumab is a humanized anti-PD1 IgG4 monoclonal antibody.

undifferentiated pleomorphic sarcoma
doxorubicin
measurable disease
monoclonal antibodies
soft tissue sarcoma
  • 0 views
  • 25 Jan, 2021
  • 1 location
A Study of N9 Chemotherapy in Children With Neuroblastoma

different times - Cyclophosphamide, topotecan, and vincristine (CTV), Ifosfamide, carboplatin, and etoposide (ICE), Cyclophosphamide, doxorubicin, and vincristine (CDV).

doxorubicin
shortening fraction
renal function
carboplatin
etoposide
  • 0 views
  • 02 Jun, 2022
  • 1 location
A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg Ifosfamide Carboplatin Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma

cHL patients. This study evaluates the safety and efficacy of PET-adapted treatment of nivolumab at the fixed dose of 40 mg in combination with ifosfamide, carboplatin, and etoposide (NICE-40) in

refractory hodgkin lymphoma
classical hodgkin lymphoma
nivolumab
cell transplantation
etoposide
  • 0 views
  • 06 Aug, 2021
  • 3 locations
Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas (ImmunoSarc)

, non-compliance, withdrawal of consent by the patient or investigator decision. C 7 Objective: To determine the MTD of the epirubicin + ifosfamide + nivolumab combination in

undifferentiated pleomorphic sarcoma
methotrexate
measurable disease
platelet count
progressive disease
  • 94 views
  • 25 Feb, 2022
  • 13 locations
Pemetrexed Cisplatin With Soft Tissue Sarcoma

18 months. Doxorubicin and ifosfamide given each alone or in their combination have represented the mainstream of anticancer treatments in metastatic STS. However, salvage treatments for patients

  • 0 views
  • 02 May, 2021
  • 1 location
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

Patients are in 2 cohorts: Cohort 1: dexamethasone, methotrexate, ifosfamide, pegaspargase, and etoposide (modified SMILE) chemotherapy regimen alone and pembrolizumab in children

dexamethasone
methotrexate
t-cell lymphoma
enteropathy
anaplastic large cell lymphoma
  • 39 views
  • 28 Feb, 2022
  • 2 locations
Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma

and ifosfamide and this combination (MAPI), given preoperatively and postoperatively, is widely used for the treatment of osteosarcoma in China. Apatinib also has activity in advanced setting and when

metastatic disease
left ventricular fractional shortening
methotrexate
cancer
serum bilirubin
  • 6 views
  • 25 Jan, 2021
  • 1 location
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

, etoposide, ifosfamide, and thiotepa, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation

beta-human chorionic gonadotropin
alpha fetoprotein
cancer
carcinoma
platelet count
  • 0 views
  • 27 Jun, 2022
  • 31 locations
Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis (MEGACEP)

patients in order to increase the response rate to treatment and survival. From a Phase II trial conducted on 30 patients, the combination TIP (paclitaxel, ifosfamide, and cisplatin) appears to

paclitaxel
metastasis
cancer
squamous cell carcinoma
immunomodulator
  • 15 views
  • 23 Feb, 2022
  • 15 locations